Skip to content
10-Q

Quarterly Report

Intercept Pharmaceuticals, Inc.

0001558370-23-012896

← back to feed
Filed
Aug 2, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q2 2023 · Jun 30, 2023 41.73M sh
Shares Diluted Q2 2023 · Jun 30, 2023 41.7M sh
Shares Diluted Q2 2023 · Jun 30, 2022 29.75M sh
Shares Diluted Q2 2023 · Jun 30, 2022 29.72M sh
Shares Outstanding Q2 2023 · Jun 30, 2023 41.78M sh
Capex Q2 2023 · Jun 30, 2023 $98K
Capex Q2 2023 · Jun 30, 2022 $531K
Operating Cash Flow Q2 2023 · Jun 30, 2023 −$74.9M
Operating Cash Flow Q2 2023 · Jun 30, 2022 −$5.39M
Long Term Debt Q2 2023 · Jun 30, 2023 $223.6M
Long Term Debt Q2 2023 · Dec 31, 2022 $223.1M
Short Term Debt Q2 2023 · Jun 30, 2023 $109.81M
Short Term Debt Q2 2023 · Dec 31, 2022 $109.57M
Cash And Equivalents Q2 2023 · Jun 30, 2023 $136.23M
Cash And Equivalents Q2 2023 · Dec 31, 2022 $50.52M
Cash And Equivalents Q2 2023 · Jun 30, 2022 $58.02M
Stockholders Equity Q2 2023 · Jun 30, 2023 $67.55M
Stockholders Equity Q2 2023 · Mar 31, 2023 $67.19M
Stockholders Equity Q2 2023 · Dec 31, 2022 $93.08M
Stockholders Equity Q2 2023 · Jun 30, 2022 −$369.83M
Stockholders Equity Q2 2023 · Mar 31, 2022 −$371.76M
Stockholders Equity Q2 2023 · Dec 31, 2021 −$183.96M
Current Liabilities Q2 2023 · Jun 30, 2023 $187.02M
Current Liabilities Q2 2023 · Dec 31, 2022 $230.08M
Total Liabilities Q2 2023 · Jun 30, 2023 $417.09M
Total Liabilities Q2 2023 · Dec 31, 2022 $460.63M
Current Assets Q2 2023 · Jun 30, 2023 $470.77M
Current Assets Q2 2023 · Dec 31, 2022 $540.13M
Total Assets Q2 2023 · Jun 30, 2023 $484.64M
Total Assets Q2 2023 · Dec 31, 2022 $553.71M
Eps Diluted Q2 2023 · Jun 30, 2023 −$0.14
Eps Diluted Q2 2023 · Jun 30, 2023 −$0.91
Eps Diluted Q2 2023 · Jun 30, 2022 −$0.25
Eps Diluted Q2 2023 · Jun 30, 2022 −$0.83
Eps Basic Q2 2023 · Jun 30, 2023 −$0.14
Eps Basic Q2 2023 · Jun 30, 2023 −$0.91
Eps Basic Q2 2023 · Jun 30, 2022 −$0.25
Eps Basic Q2 2023 · Jun 30, 2022 −$0.83
Sga Expense Q2 2023 · Jun 30, 2023 $53.35M
Sga Expense Q2 2023 · Jun 30, 2023 $111M
Sga Expense Q2 2023 · Jun 30, 2022 $39.99M
Sga Expense Q2 2023 · Jun 30, 2022 $77.74M
Rd Expense Q2 2023 · Jun 30, 2023 $37.31M
Rd Expense Q2 2023 · Jun 30, 2023 $79.02M
Rd Expense Q2 2023 · Jun 30, 2022 $44.83M
Rd Expense Q2 2023 · Jun 30, 2022 $92.72M
Net Income Q2 2023 · Jun 30, 2023 −$5.86M
Net Income Q2 2023 · Jun 30, 2023 −$38M
Net Income Q2 2023 · Jun 30, 2022 −$7.53M
Net Income Q2 2023 · Jun 30, 2022 −$24.81M
Operating Income Q2 2023 · Jun 30, 2023 −$7.12M
Operating Income Q2 2023 · Jun 30, 2023 −$38.75M
Operating Income Q2 2023 · Jun 30, 2022 −$13.36M
Operating Income Q2 2023 · Jun 30, 2022 −$40.09M
Cost Of Revenue Q2 2023 · Jun 30, 2023 $185K
Cost Of Revenue Q2 2023 · Jun 30, 2023 $407K
Cost Of Revenue Q2 2023 · Jun 30, 2022 $309K
Cost Of Revenue Q2 2023 · Jun 30, 2022 $532K
Revenue Q2 2023 · Jun 30, 2023 $83.72M
Revenue Q2 2023 · Jun 30, 2023 $151.68M
Revenue Q2 2023 · Jun 30, 2022 $71.76M
Revenue Q2 2023 · Jun 30, 2022 $130.9M